Following a long-awaited submission of data to the FDA last month, Novavax announced this week that it had formally filed a request for emergency use authorization of its protein-based COVID-19 vaccine in the United States.
In a social media landscape shaped by hashtags, algorithms, and viral posts, nurse leaders must decide: Will they let the narrative spiral, or can they adapt and join the conversation?
...
